Literature DB >> 23893293

Adult female rats' altered diurnal locomotor activity pattern following chronic methylphenidate treatment.

T N Trinh1, S R Kohllepel, P B Yang, K D Burau, N Dafny.   

Abstract

Methylphenidate (MPD) is one of the most prescribed pharmacological agents, which is also used for cognitive enhancement and recreational purposes. The objective of this study was to investigate the repetitive dose-response effects of MPD on circadian rhythm of locomotor activity pattern of female WKY rats. The hypothesis is that a change in the circadian activity pattern indicates a long-lasting effect of the drug. Four animal groups (saline control, 0.6, 2.5, and 10.0 mg/kg MPD dose groups) were housed in a sound-controlled room at 12:12 light/dark cycle. All received saline injections on experimental day 1 (ED 1). On EDs 2-7, the control group received saline injection; the other groups received 0.6, 2.5, or 10.0 mg/kg MPD, respectively. On ED 8-10, injections were withheld. On ED 11, each group received the same dose as EDs 2-7. Hourly histograms and cosine statistical analyses calculating the acrophase (ϕ), amplitude (A), and MESOR (M) were applied to assess the 24-h circadian activity pattern. The 0.6 and 2.5 mg/kg MPD groups exhibited significant (p < 0.05) change in their circadian activity pattern on ED 11. The 10.0 mg/kg MPD group exhibited tolerance on ED 11 and also a significant change in activity pattern on ED 8 compared to ED 1, consistent with withdrawal behavior (p < 0.007). In conclusion, chronic MPD administration alters circadian locomotor activity of adult female WKY rats and confirms that chronic MPD use elicits long-lasting effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893293      PMCID: PMC4036815          DOI: 10.1007/s00702-013-1063-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  109 in total

Review 1.  Coordination of circadian timing in mammals.

Authors:  Steven M Reppert; David R Weaver
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

2.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

3.  Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.

Authors:  N D Volkow; G J Wang; J S Fowler; M Fischman; R Foltin; N N Abumrad; S J Gatley; J Logan; C Wong; A Gifford; Y S Ding; R Hitzemann; N Pappas
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 4.  The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects.

Authors:  Nachum Dafny; Pamela B Yang
Journal:  Brain Res Bull       Date:  2005-10-27       Impact factor: 4.077

5.  Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.

Authors:  S Izenwasser; A E Coy; B Ladenheim; R J Loeloff; J L Cadet; D French
Journal:  Eur J Pharmacol       Date:  1999-06-04       Impact factor: 4.432

6.  Valproate modulates the expression of methylphenidate (ritalin) sensitization.

Authors:  P Yang; A Beasley; A Swann; N Dafny
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

7.  MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate.

Authors:  O Gaytan; R Nason; R Alagugurusamy; A Swann; N Dafny
Journal:  Brain Res Bull       Date:  2000-04       Impact factor: 4.077

8.  Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum.

Authors:  Cindy L Brandon; Heinz Steiner
Journal:  Eur J Neurosci       Date:  2003-09       Impact factor: 3.386

9.  Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment.

Authors:  Carlos A Hernandez-Avila; Bruce J Rounsaville; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

10.  Circadian control of the daily plasma glucose rhythm: an interplay of GABA and glutamate.

Authors:  Andries Kalsbeek; Ewout Foppen; Ingrid Schalij; Caroline Van Heijningen; Jan van der Vliet; Eric Fliers; Ruud M Buijs
Journal:  PLoS One       Date:  2008-09-15       Impact factor: 3.240

View more
  5 in total

1.  Acute and chronic psychostimulant treatment modulates the diurnal rhythm activity pattern of WKY female adolescent rats.

Authors:  Cathleen G Jones; Pamela B Yang; Victor T Wilcox; Keith D Burau; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2014-01-31       Impact factor: 3.575

2.  Impact of adult attention deficit hyperactivity disorder and medication status on sleep/wake behavior and molecular circadian rhythms.

Authors:  A N Coogan; M Schenk; D Palm; A Uzoni; J Grube; A H Tsang; I Kolbe; N M McGowan; R Wandschneider; M Colla; H Oster; J Thome; F Faltraco
Journal:  Neuropsychopharmacology       Date:  2019-02-06       Impact factor: 7.853

3.  Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role of CREB/BDNF signaling pathway.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Reza Falak; Mansour Heidari; Mahshid Sharzad; Elham Kalantari
Journal:  J Neural Transm (Vienna)       Date:  2016-09-24       Impact factor: 3.575

4.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

5.  Time-shifting effects of methylphenidate on daily rhythms in the diurnal rodent Arvicanthis ansorgei.

Authors:  Jorge Mendoza; Hester C van Diepen; Rob Rodrigues Pereira; Johanna H Meijer
Journal:  Psychopharmacology (Berl)       Date:  2018-05-18       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.